These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11834772)

  • 1. Diabetic nephropathy: how effective is treatment in clinical practice?
    Joss N; Paterson KR; Deighan CJ; Simpson K; Boulton-Jones JM
    QJM; 2002 Jan; 95(1):41-9. PubMed ID: 11834772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
    Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The joint diabetic-renal clinic in clinical practice: 10 years of data from a District General Hospital.
    Jayapaul MK; Messersmith R; Bennett-Jones DN; Mead PA; Large DM
    QJM; 2006 Mar; 99(3):153-60. PubMed ID: 16497849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective review of diabetic nephropathy patients during referral to the sub-urban nephrology clinic.
    Menon R; Mohd Noor FS; Draman CR; Seman MR; Ghani AS
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):1109-14. PubMed ID: 22982937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy and progression of diabetic nephropathy.
    Rossing K; Jacobsen P; Hommel E; Mathiesen E; Svenningsen A; Rossing P; Parving HH
    Diabetologia; 2002 Jan; 45(1):36-41. PubMed ID: 11845221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-risk diabetic nephropathy patients: the outcome of evidence-based clinical practice in an outpatient clinic.
    Slade H; Williams SM; Manning PJ; Walker RJ
    Diabetes Res Clin Pract; 2011 Jun; 92(3):356-60. PubMed ID: 21411171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensified treatment of patients with type 2 diabetes mellitus and overt nephropathy.
    Joss N; Ferguson C; Brown C; Deighan CJ; Paterson KR; Boulton-Jones JM
    QJM; 2004 Apr; 97(4):219-27. PubMed ID: 15028852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of structured care by a pharmacist-diabetes specialist team in patients with type 2 diabetic nephropathy.
    Leung WY; So WY; Tong PC; Chan NN; Chan JC
    Am J Med; 2005 Dec; 118(12):1414. PubMed ID: 16378791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ; Lewis JB
    Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
    Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic nephropathy and chronic kidney disease at a busy diabetes clinic: a study of outpatient care and suggestions for improved care pathways at a subspecialty specialist diabetic renal clinic.
    Graham UM; Magee GM; Hunter SJ; Atkinson AB
    Ulster Med J; 2010 May; 79(2):57-61. PubMed ID: 21116420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
    Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
    Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal protection in diabetes--an emerging role for calcium antagonists.
    Parving HH; Tarnow L; Rossing P
    Cardiology; 1997; 88 Suppl 3():56-62. PubMed ID: 9397296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.
    Lewis EJ; Hunsicker LG; Bain RP; Rohde RD
    N Engl J Med; 1993 Nov; 329(20):1456-62. PubMed ID: 8413456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: post hoc analysis of the Irbesartan Diabetic Nephropathy Trial.
    Evans M; Bain SC; Hogan S; Bilous RW;
    Nephrol Dial Transplant; 2012 Jun; 27(6):2255-63. PubMed ID: 22172728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.
    de Zeeuw D; Remuzzi G; Parving HH; Keane WF; Zhang Z; Shahinfar S; Snapinn S; Cooper ME; Mitch WE; Brenner BM
    Kidney Int; 2004 Jun; 65(6):2309-20. PubMed ID: 15149345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaemia is common and predicts mortality in diabetic nephropathy.
    Joss N; Patel R; Paterson K; Simpson K; Perry C; Stirling C
    QJM; 2007 Oct; 100(10):641-7. PubMed ID: 17921197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy.
    Sanaka T; Akizawa T; Koide K; Koshikawa S
    Ther Apher Dial; 2004 Jun; 8(3):232-40. PubMed ID: 15154877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in the progression of diabetic nephropathy according to racial origin.
    Earle KK; Porter KA; Ostberg J; Yudkin JS
    Nephrol Dial Transplant; 2001 Feb; 16(2):286-90. PubMed ID: 11158401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.